A detailed history of Shelton Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Shelton Capital Management holds 143,738 shares of MRK stock, worth $14.1 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
143,738
Previous 115,708 24.22%
Holding current value
$14.1 Million
Previous $14.3 Million 13.95%
% of portfolio
0.42%
Previous 0.4%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $3.12 Million - $3.62 Million
28,030 Added 24.22%
143,738 $16.3 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $2.44 Million - $2.62 Million
19,686 Added 20.5%
115,708 $14.3 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $10.9 Million - $12.7 Million
96,022 New
96,022 $12.7 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $3.01 Million - $3.27 Million
30,038 Added 28.42%
135,730 $14.8 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $10.9 Million - $12.1 Million
105,692 New
105,692 $10.9 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $3.72 Million - $4.06 Million
34,281 Added 72.61%
81,492 $9.4 Million
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $3.73 Million - $4.16 Million
36,211 Added 329.19%
47,211 $5.02 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $15.8 Million - $20.3 Million
-180,815 Reduced 94.27%
11,000 $1.22 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $1.33 Million - $1.49 Million
15,704 Added 8.92%
191,815 $16.5 Million
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $2.7 Million - $3.06 Million
-32,296 Reduced 15.5%
176,111 $16.1 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $2.73 Million - $3.06 Million
37,189 Added 21.72%
208,407 $17.1 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $5.94 Million - $7.45 Million
82,244 Added 92.44%
171,218 $13.1 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $435,742 - $479,207
-6,079 Reduced 6.4%
88,974 $6.68 Million
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $7.96 Million - $8.81 Million
-113,252 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $7.8 Million - $9.19 Million
113,252 New
113,252 $8.73 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $2.15 Million - $2.38 Million
29,900 Added 38.72%
107,116 $8.76 Million
Q3 2020

Nov 09, 2020

BUY
$73.18 - $82.95 $964,000 - $1.09 Million
13,173 Added 20.57%
77,216 $6.41 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $2.06 Million - $2.35 Million
29,300 Added 84.33%
64,043 $4.95 Million
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $3.45 Million - $4.78 Million
-54,440 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$77.58 - $87.54 $369,358 - $416,777
-4,761 Reduced 8.04%
54,440 $4.95 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $4.5 Million - $4.91 Million
59,201 New
59,201 $4.98 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $3.79 Million - $4.43 Million
54,272 Added 1083.06%
59,283 $4.97 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $2.06 Million - $2.35 Million
-29,637 Reduced 85.54%
5,011 $60.2 Million
Q4 2018

Jan 31, 2019

SELL
$65.24 - $75.71 $2.28 Million - $2.65 Million
-34,948 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $648,147 - $762,182
-11,235 Reduced 24.33%
34,948 $2.48 Million
Q2 2018

Aug 10, 2018

BUY
$50.83 - $59.72 $2.35 Million - $2.76 Million
46,183 New
46,183 $2.8 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $8,255 - $9,595
-162 Reduced 0.31%
52,648 $2.87 Million
Q4 2017

Feb 06, 2018

SELL
$51.62 - $61.64 $2.73 Million - $3.26 Million
-52,810 Closed
0 $0
Q2 2017

Aug 14, 2017

SELL
N/A
-803 Reduced 1.5%
52,810 $3.39 Million
Q1 2017

Nov 28, 2017

SELL
N/A
-8,800 Reduced 14.1%
53,613 $3.41 Million
Q3 2016

Dec 06, 2017

BUY
N/A
61,654 New
61,654 $3.85 Million
Q3 2016

Dec 04, 2017

BUY
N/A
62,413
62,413 $3.67 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.